Lanabiotic Availability: What Providers and Prescribers Need to Know in 2026

Patients are increasingly asking their providers why they can't find Lanabiotic at local pharmacies. While Lanabiotic (neomycin / polymyxin B / pramoxine topical ointment) is not on the FDA's drug shortage list, the OTC landscape creates real barriers to access that clinical teams should understand in order to counsel patients effectively and document therapeutic substitutions when appropriate.

Clinical Overview: What Is Lanabiotic?

Lanabiotic is an OTC topical antibiotic ointment combining three active agents:

• Neomycin Sulfate (3.5 mg/g): Aminoglycoside antibiotic; inhibits 30S ribosomal protein synthesis; active against gram-positive and gram-negative organisms including Staphylococcus aureus, Escherichia coli, and Proteus species.

• Polymyxin B Sulfate (10,000 units/g): Disrupts bacterial outer membrane phospholipid layer; bactericidal against gram-negative organisms including Pseudomonas aeruginosa.

• Pramoxine HCl (10 mg/g): Topical local anesthetic; stabilizes neuronal membranes, reducing pain signal transmission. Provides symptomatic relief for wound-related pain and itching.

Its primary indication is first-aid prevention of infection in minor cuts, abrasions, and burns. It is FDA-approved as an OTC product and has not been withdrawn for safety or effectiveness reasons.

Why Your Patients Are Having Trouble Finding Lanabiotic

There is no FDA-confirmed national shortage of Lanabiotic. However, the following OTC market dynamics create genuine access barriers at the patient level:

• Brand dominance by Neosporin: Johnson & Johnson's Neosporin line controls the majority of OTC triple antibiotic shelf space at most national pharmacy chains, leaving limited room for competing brands.

• No pharmacy stocking mandate: Pharmacies are not obligated to stock specific OTC brands. A chain pharmacy may not carry Lanabiotic at any of its locations.

• Seasonal demand variability: Summer and back-to-school periods generate surges in OTC antibiotic ointment demand, leading to temporary sellouts.

Clinical Alternatives to Consider When Lanabiotic Is Unavailable

When counseling patients who cannot access Lanabiotic, consider the following evidence-based alternatives organized by clinical scenario:

Equivalent OTC substitutes (same active ingredient class):

• Neosporin + Pain Relief Ointment: neomycin + polymyxin B + bacitracin + pramoxine — closest equivalent, adds gram-positive bacitracin coverage.

• Generic triple antibiotic + pain relief: same formulation as Neosporin + Pain Relief; lower cost, equally effective.

Neomycin-sensitive patients (contact dermatitis risk):

• Polysporin (bacitracin + polymyxin B): double antibiotic without neomycin; appropriate for patients with known neomycin sensitivity.

• Plain bacitracin zinc ointment: single-agent topical antibiotic with the lowest allergy risk profile.

For infected or serious wounds requiring prescription therapy:

• Mupirocin (Bactroban) 2% ointment: effective for impetigo and Staph/Strep skin infections; FDA-approved for skin infections not appropriate for OTC therapy.

• Retapamulin (Altabax) 1% ointment: second-line option for impetigo in patients with mupirocin resistance concerns.

A Note on Antibiotic Stewardship and OTC Topical Antibiotics

Clinicians should note that ongoing research has raised concerns about OTC triple antibiotic ointments potentially contributing to antibiotic resistance — particularly neomycin's association with increased MRSA colonization in some studies. For patients with simple, low-risk wounds where infection prevention is the primary goal, plain petrolatum (Vaseline) has demonstrated equivalent outcomes to OTC antibiotic ointments in select wound-healing studies. This may be an appropriate alternative for patients with multiple antibiotic sensitivities.

38,004+ patients found their medications in stock

38K+

Find Lanabiotic In Stock Today →

How medfinder Supports Your Patients

When patients leave your office with a recommendation for Lanabiotic and then can't find it, they often return frustrated — or abandon treatment. medfinder for providers helps close this gap by contacting pharmacies near your patients to identify which ones have the recommended medication in stock. Results are sent directly to the patient by text. See our provider's guide to helping patients find Lanabiotic for more.